The CNBC Cures Advisory Board brings together leading rare disease researchers, physicians, regulators, and patient advocacy leaders to drive meaningful, lasting impact for the rare disease community. Each board member has a personal connection to rare diseases and is united by a shared mission to advance research, develop new treatments, and elevate awareness for underserved patient populations in the rare disease space.

Sign up for weekly editions of the CNBC Cures newsletter here.